Vitamin D deficiency and exogenous vitamin D excess similarly increase diffuse atherosclerotic calcification in apolipoprotein E knockout mice

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Ellam, Timothy ^a,b   Hameed, Abdul ^a   Ul Haque, Risat ^a   Muthana, Munitta ^a   Wilkie, Martin ^b   Francis, Sheila E ^a   Chico, Timothy J A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CALCIUM PHOSPHATE; PARATHYROID HORMONE; PARICALCITOL; VITAMIN D; ERGOCALCIFEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROGENIC DIET; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC CALCIFICATION; BLOOD PRESSURE MEASUREMENT; BONE DENSITY; BONE MASS; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHATE BLOOD LEVEL; TRABECULAR BONE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D EXCESS; VITAMIN DEFICIENCY; ANIMAL; ATHEROSCLEROTIC PLAQUE; CALCINOSIS; COMPLICATION; DEFICIENCY; DIET; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; APOLIPOPROTEINS E; CALCINOSIS; DIET; ERGOCALCIFEROLS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; SINUS OF VALSALVA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84896794154     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088767     Document Type: Article

References (45)

1. Giovannucci E, Liu Y, Hollis BW, Rimm EB (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174-1180. (Pubitemid 351831400)
2. Karakas M, Thorand B, Zierer A, Huth C, Meisinger C, et al. (2013) Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. J Clin Endocrinol Metab 98: 272-280.
3. Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, et al. (2008) Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke 39: 2611-2613.
4. Brondum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M (2013) 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann Neurol 73: 38-47.
5. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, et al. (2008) Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340-1349. (Pubitemid 351930842)
6. Fiscella K, Franks P (2010) Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 8: 11-18.
7. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR (2011) 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 57: 63-69.
8. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, et al. (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755-1760. (Pubitemid 27400730)
9. Giallauria F, Milaneschi Y, Tanaka T, Maggio M, Canepa M, et al. (2012) Arterial Stiffness and Vitamin D Levels: the Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab.
10. Pilz S, Tomaschitz A, Ritz E, Pieber TR (2009) Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 6: 621-630.
11. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-2029. (Pubitemid 46997093)
12. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, et al. (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167: 1159-1165. (Pubitemid 46919818)
13. Jorde R, Grimnes G (2012) Vitamin D and lipids: do we really need more studies? Circulation 126: 252-254.
14. Rosen CJ (2011) Clinical practice. Vitamin D insufficiency. N Engl J Med 364: 248-254.
15. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, et al. (2011) Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 96: 1931-1942.
16. Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, et al. (2013) Optimal vitamin d status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 98: E1283-1304.
17. Chen S, Law CS, Grigsby CL, Olsen K, Gardner DG (2010) A role for the cell cycle phosphatase Cdc25a in vitamin D-dependent inhibition of adult rat vascular smooth muscle cell proliferation. J Steroid Biochem Mol Biol 122: 326-332.
18. Talmor Y, Golan E, Benchetrit S, Bernheim J, Klein O, et al. (2008) Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 294: F1059-1064.
19. Nelson CD, Reinhardt TA, Beitz DC, Lippolis JD (2010) In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection. PLoS One 5: e15469.
20. Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, et al. (2011) Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124: 1838-1847.
21. Verstuyf A, Carmeliet G, Bouillon R, Mathieu C (2010) Vitamin D: a pleiotropic hormone. Kidney Int 78: 140-145.
22. Xiang W, Kong J, Chen S, Cao LP, Qiao G, et al. (2005) Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288: E125-132. (Pubitemid 40023798)
23. Szeto FL, Reardon CA, Yoon D, Wang Y, Wong KE, et al. (2012) Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol 26: 1091-1101.
24. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, et al. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29: 726-776.
25. Deb DK, Sun T, Wong KE, Zhang Z, Ning G, et al. (2010) Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int 77: 1000-1009.
26. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19: 1509-1519.
27. Ellam T, Wilkie M, Chamberlain J, Crossman D, Eastell R, et al. (2011) Dietary phosphate modulates atherogenesis and insulin resistance in apolipoprotein e knockout mice-brief report. Arterioscler Thromb Vasc Biol 31: 1988-1990.
28. Gross ML, Meyer HP, Ziebart H, Rieger P, Wenzel U, et al. (2007) Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol 2: 121-134.
29. Schmidt N, Brandsch C, Kuhne H, Thiele A, Hirche F, et al. (2012) Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One 7: e35316.
30. Omdahl JL, Morris HA, May BK (2002) Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 22: 139-166. (Pubitemid 35221457)
31. Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27: 2302-2309. (Pubitemid 350203943)
32. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E (2006) Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 21: 484-490.
33. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, et al. (2009) 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 20: 1805-1812.
34. Shen H, Bielak LF, Ferguson JF, Streeten EA, Yerges-Armstrong LM, et al. (2010) Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol 30: 2648-2654.
35. Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-o M, et al. (2012) Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int 82: 1261-1270.
36. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, et al. (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19: 1239-1246.
37. Li X, Speer MY, Yang H, Bergen J, Giachelli CM (2010) Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin. Arterioscler Thromb Vasc Biol 30: 321-326.
38. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, et al. (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45: 1026-1033. (Pubitemid 40806515)
39. Zhou S, LeBoff MS, Glowacki J (2010) Vitamin D metabolism and action in human bone marrow stromal cells. Endocrinology 151: 14-22.
40. Weng S, Sprague JE, Oh J, Riek AE, Chin K, et al. (2013) Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS One 8: e54625.
41. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, et al. (2010) Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol 30: 2495-2503.
42. Becker LE, Koleganova N, Piecha G, Noronha IL, Zeier M, et al. (2011) Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. Am J Physiol Renal Physiol 300: F772-782.
43. Ellam TJ, Chico TJ (2012) Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220: 310-318.
44. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B (2004) Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 116: 634-639. (Pubitemid 38490539)
45. The VITAL Study. Available: http://clinicaltrials.gov/show/NCT01169259 Accessed 2013 Aug 8.